INquiraey4

Hello! I'm working on an upper-limb prosthetics project, so I'll have a few questions here...

Based on the few articles you linked, I'm getting the impression that the Linx acts almost independently of the user - it predicts the user's action and adapts for it to allow movement, but the user has no direct control over the device. Is that correct?

Is the device entirely passive, or does it have active dorsi/plantarflexion options, and would there be an advantage to one over the other?

What is the next limiting factor in improving lower limb prosthetics?

Career wise, how did you get to technical director?

Thanks!

Thank you for your response!

Does the linx foot system only allow for dorsi/plantar flexion, or are rotation and inversion/eversion also supported? Is there an advantage to adding these if they are not available, or would they complicate the system excessively?

Compared to upper limb prosthetics, lower limb devices have a much larger available market. It is one thing to make a new device, and another to make something that can be commercially viable - and so actually improve quality of life on a large scale. How much does commercial opportunity limit or promote advancing prosthetics? How do they factor into R&D priorities?

Is the Linx only available in the UK? What determines whether expansion into international markets is warranted, and are there plans to expand?

Thanks again!